Sansera Engineering (Sansera) is an integrated manufacturer of precision forged and machined components, serving global OEMs ...

These shares are ending the year in the red. Let's see what is going on. The post Why AVITA Medical, Life360, Newmont, and St ...

diwali design png AstraZeneca's tezepelumab fails in phase III study for severe asthma The first new drug in 20 years! Johnson & Johnson's Invokana (canagliflozin) is approved by the US FDA Affected ...

Cabinet also considered defence cooperation with Papua New Guinea, participation in the Regional Assistance ... By March 2004 ...

The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

The approval of Opdivo Qvantig was supported by data from the randomized, open-label phase 3 CheckMate-67T study.

Neffy for severe allergic reactions and Dupixent for chronic obstructive pulmonary disease (COPD), which all gained FDA approval this year. These medications are "slated to make a big clinical ...

The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory ...